07.01.02
Innovative Technology Acquisition Corporation, BST Sign Letter of Intent
Innovative Technology Acquisition Corporation, Toronto, Canada, has entered into a letter of intent to acquire 100% of BioSource Therapeutics, Inc. (BST), a life science biotechnology corporation dedicated to the research and development of innovative dietary supplements that address the effects of epidemic viral infections. BioSource Therapeutics will be actively pursuing clinical trials for its dietary supplement, which will lead toward market approval for insurance reimbursement in North American and European markets.
Innovative Technology Acquisition Corporation, Toronto, Canada, has entered into a letter of intent to acquire 100% of BioSource Therapeutics, Inc. (BST), a life science biotechnology corporation dedicated to the research and development of innovative dietary supplements that address the effects of epidemic viral infections. BioSource Therapeutics will be actively pursuing clinical trials for its dietary supplement, which will lead toward market approval for insurance reimbursement in North American and European markets.